Kestra Medical Technologies, Ltd. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Kestra Medical Technologies, Ltd. (KMTS) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$34.17 million for the 3-month period ending 2026-01-31, per its 10-Q filed 2026-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-03-17
- Kestra Medical Technologies, Ltd. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-01-31 was -$34.17M.
- Kestra Medical Technologies, Ltd. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-10-31 was -$32.78M.
- Kestra Medical Technologies, Ltd. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-07-31 was -$25.83M.
- Kestra Medical Technologies, Ltd. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-01-31 was -$21.76M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2026-01-31 | -$34.17M 10-Q · filed 2026-03-17 | -$66.95M derived: sum of 2 quarters · filed 2026-03-17 | -$92.78M 10-Q · filed 2026-03-17 |
| 2025-10-31 | -$32.78M 10-Q · filed 2025-12-11 | -$58.61M 10-Q · filed 2025-12-11 | |
| 2025-07-31 | -$25.83M 10-Q · filed 2025-09-12 | ||
| 2025-01-31 | -$21.76M 10-Q · filed 2026-03-17 | -$42.38M derived: sum of 2 quarters · filed 2026-03-17 | -$62.70M 10-Q · filed 2026-03-17 |
| 2024-10-31 | -$20.62M 10-Q · filed 2025-12-11 | -$40.94M 10-Q · filed 2025-12-11 | |
| 2024-07-31 | -$20.32M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |